Ÿnsect On Track To Enter The Human Food Market With A Positive Assessment From The EFSA
USA - English
Share this article
PARIS, Jan. 13, 2021 /PRNewswire/ -- Getting the provisional green light from the EFSA
[1] is a major step forward for the industry. It should pave the way for future approvals, particularly on human consumption of defatted insect protein, which represents the largest human food market segment in terms of value and volumes, especially in sports and health nutrition.
Ÿnsect has identified these markets as the most promising with YnMeal, one of its defatted ingredients.
Ÿnsect has submitted its Novel Food application (without requesting information protection for five years, so that its data can be used by all within the European sector) demonstrating an allergen profile much lower than using the whole insect.